National Express Group PLC
31 May 2007
National Express Group PLC ('NEG') - Voting Rights and Capital
In accordance with the FSA's Disclosure and Transparency Rule 5.6.1 we would
like to notify the market of the following:
As at 31st May 2007 the issued share capital of NEG consists of 154,487,998
ordinary shares of 5 pence each with voting rights.
The total shares in issue have increased from 154,059,599 as at 30th April 2007
to 154,487,998 shares as at 31st May 2007 as a result of shares issued to
satisfy the exercise of share options by employees.
NEG holds 1,825,000 ordinary shares in treasury. Therefore the total number of
voting rights in NEG is 152,662,998 ordinary shares of 5 pence each.
The above figure (152,662,998) may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, NEG under the FSA's
Disclosure and Transparency Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.